Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Eccentric vs. Concentric Ankle Training in Multiple Sclerosis

8 de novembro de 2026 atualizado por: Al Hayah University In Cairo

Effect of Eccentric Versus Concentric Ankle Dorsiflexor Training on Dynamic Plantar Pressure Parameters During Walking in Patients With Multiple Sclerosis

Multiple sclerosis is a chronic neurological disease that can cause muscle weakness, impaired walking, and difficulty controlling ankle movement. Foot drop is a common gait impairment in people with multiple sclerosis and occurs when weakness of the ankle dorsiflexor muscles limits the ability to lift the foot during walking.

This randomized controlled clinical trial aims to compare the effects of eccentric and concentric ankle dorsiflexor resistance training on ankle muscle strength and dynamic plantar pressure parameters during walking in adults with relapsing-remitting multiple sclerosis and foot drop.

A total of 54 participants are planned for enrollment. Eligible participants will be randomly allocated to two parallel groups, with 27 participants assigned to each group. The first group will perform eccentric ankle dorsiflexor training, while the second group will perform concentric ankle dorsiflexor training. Both groups will also receive the same standardized conventional physical therapy program.

The intervention will consist of three treatment sessions per week for six weeks, with each session lasting approximately 45 minutes. Ankle dorsiflexor resistance training will be performed using graded elastic resistance bands.

The primary outcome measures will be concentric and eccentric ankle dorsiflexor peak torque, assessed using a HUMAC NORM isokinetic dynamometer. Secondary outcome measures will include total plantar force, maximum plantar pressure, plantar contact surface area, and plantar contact time during walking, assessed using the DIERS pedoscan plantar pressure measurement system.

Measurements will be obtained before and after the six-week intervention period. The study will determine whether eccentric and concentric ankle dorsiflexor training produce different effects on muscle strength and dynamic plantar loading in individuals with multiple sclerosis and foot drop.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

54

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • Cairo Governorate
      • New Cairo, Cairo Governorate, Egito, 12611
        • Recrutamento
        • Alhayah University in Cairo
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

20 anos a 40 anos (Adulto)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Adults aged between 20 and 40 years.
  • Clinically confirmed diagnosis of relapsing-remitting multiple sclerosis, based on neurological evaluation, MRI findings, and relevant medical records.
  • Medically stable multiple sclerosis without relapse during the preceding three months.
  • Clinically evident foot drop secondary to ankle dorsiflexor muscle weakness, with a manual muscle testing grade of 3/5 or less.
  • Expanded Disability Status Scale (EDSS) score between 1.0 and 6.0.
  • Ability to walk independently, with or without the participant's usual assistive device.
  • Mini-Mental State Examination (MMSE) score between 25 and 30.
  • Body mass index below 30 kg/m².
  • Willingness to participate in the study and provision of written informed consent.

Exclusion Criteria:

  • Neurological disorders other than multiple sclerosis that could influence gait, including stroke, Parkinson's disease, peripheral neuropathy, or spinal cord injury.
  • Significant orthopedic disorders affecting the lower limbs or spine that could interfere with gait performance.
  • Recent lower-limb surgery or significant musculoskeletal injury.
  • Severe ankle spasticity that prevents appropriate performance of the dorsiflexor training protocol.
  • Severe balance impairment that makes participation in the training program unsafe.
  • Severe visual, vestibular, or cognitive impairment that prevents reliable study participation.
  • Significant cardiopulmonary disease or other medical conditions contraindicating physical exercise.
  • Current participation in a structured lower-limb strengthening program specifically targeting the ankle dorsiflexor muscles.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Eccentric Ankle Dorsiflexor Training

Participants assigned to this group will receive eccentric ankle dorsiflexor resistance training using graded elastic resistance bands, in addition to a standardized conventional physical therapy program. Eccentric exercise will emphasize controlled ankle movement from dorsiflexion toward plantarflexion against elastic resistance, with assisted or passive return to the starting position. Training will include three sets of ten repetitions, with one to two minutes of rest between sets. Sessions will be performed three times per week for six weeks.

Participants will begin with the ankle positioned in dorsiflexion. A graded elastic resistance band attached to the forefoot will apply a plantarflexion-directed force. Participants will slowly control movement toward plantarflexion against band resistance, producing eccentric contraction of the ankle dorsiflexor muscles. Return to the starting position will be passive or assisted to minimize concentric dorsiflexor activity. Training will consist of three sets of ten repetitions per session, with one to two minutes of rest between sets. Sessions will occur three times weekly for six weeks. Band resistance will progress weekly according to participant tolerance and movement quality.

Both groups will receive identical conventional physical therapy consisting of upper-limb strengthening for shoulder and elbow muscle groups; flexibility exercises with 20-60-second stretching holds; postural correction; abdominal and trunk-extensor strengthening; relaxation and controlled breathing; and education on fatigue management and energy conservation. Upper-limb and trunk exercises will generally involve 5-10 repetitions with progression according to tolerance. Conventional therapy and ankle-specific resistance exercises will be delivered within 45-minute treatment sessions, three times weekly for six weeks.

Comparador Ativo: Concentric Ankle Dorsiflexor Training

Participants assigned to this group will receive concentric ankle dorsiflexor resistance training using graded elastic resistance bands, in addition to the same standardized conventional physical therapy program. Concentric exercise will emphasize active movement from plantarflexion toward dorsiflexion against elastic resistance, with an assisted or minimally resisted return movement. Training will include three sets of ten repetitions, with one to two minutes of rest between sets. Sessions will be performed three times per week for six weeks.

Both groups will receive identical conventional physical therapy consisting of upper-limb strengthening for shoulder and elbow muscle groups; flexibility exercises with 20-60-second stretching holds; postural correction; abdominal and trunk-extensor strengthening; relaxation and controlled breathing; and education on fatigue management and energy conservation. Upper-limb and trunk exercises will generally involve 5-10 repetitions with progression according to tolerance. Conventional therapy and ankle-specific resistance exercises will be delivered within 45-minute treatment sessions, three times weekly for six weeks.

Participants will begin with the ankle positioned in plantarflexion. A graded elastic resistance band attached to the forefoot will oppose active dorsiflexion. Participants will actively move the ankle from plantarflexion toward dorsiflexion against resistance, producing concentric contraction of the ankle dorsiflexor muscles. Return toward plantarflexion will be assisted or performed with minimal resistance to minimize the eccentric training component. Training will consist of three sets of ten repetitions per session, with one to two minutes of rest between sets. Sessions will occur three times weekly for six weeks, with weekly progression based on tolerance and movement control.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Concentric Ankle Dorsiflexor Peak Torque (Nm)
Prazo: Baseline and at the end of the 6-week intervention.

Maximum torque generated by the ankle dorsiflexor muscles during concentric contraction, measured using the HUMAC NORM computerized isokinetic dynamometer at an angular velocity of 60 degrees per second. Following a standardized warm-up and three to five submaximal practice repetitions, three maximal concentric contractions will be performed. The highest recorded torque will be expressed in Newton-meters (Nm). Assessments will be performed before and after the intervention period.

Baseline and at the end of the 6-week intervention.
Eccentric Ankle Dorsiflexor Peak Torque (Nm)
Prazo: Baseline and at the end of the 6-week intervention.

Maximum torque generated by the ankle dorsiflexor muscles during eccentric contraction, measured using the HUMAC NORM computerized isokinetic dynamometer at an angular velocity of 60 degrees per second. Following a standardized warm-up and three to five submaximal practice repetitions, three maximal eccentric contractions will be performed. The highest recorded torque will be expressed in Newton-meters (Nm). Assessments will be performed before and after the intervention period.

Baseline and at the end of the 6-week intervention.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Total Plantar Force During Walking (N)
Prazo: Baseline and at the end of the 6-week intervention.

Total vertical force exerted by the foot on the pressure-sensitive platform during foot-ground contact while walking, measured using the DIERS pedoscan plantar pressure assessment system. Participants will walk barefoot across the platform at their self-selected comfortable walking speed. The measured force will be expressed in Newtons (N). Multiple walking trials will be completed, and mean values from valid trials will be used for analysis.

Baseline and at the end of the 6-week intervention.
Maximum Plantar Pressure During Walking (N/cm²)
Prazo: Baseline and at the end of the 6-week intervention.

The highest plantar pressure recorded at any location beneath the foot during the stance phase of walking, measured using the DIERS pedoscan plantar pressure system. Participants will walk barefoot across the pressure-sensitive platform at a self-selected comfortable speed. Maximum plantar pressure will be expressed in Newtons per square centimeter (N/cm²). Mean values from valid walking trials will be used for analysis.

Baseline and at the end of the 6-week intervention.
Plantar Contact Surface Area During Walking (cm²)
Prazo: Baseline and at the end of the 6-week intervention.

The area of the plantar surface that makes contact with the pressure-sensitive platform during walking, measured using the DIERS pedoscan plantar pressure assessment system. Plantar contact area will be expressed in square centimeters (cm²). Participants will walk barefoot at a self-selected comfortable walking speed, and mean values obtained from valid trials will be used for analysis.

Baseline and at the end of the 6-week intervention.
Plantar Contact Time During Walking (ms)
Prazo: Baseline and at the end of the 6-week intervention.

The duration of foot-ground contact during a step, measured using the DIERS pedoscan plantar pressure assessment system. Contact time will be expressed in milliseconds (ms). Participants will walk barefoot across the platform at a self-selected comfortable walking speed. Multiple trials will be completed, and the mean contact time from valid trials will be used for analysis.

Baseline and at the end of the 6-week intervention.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

18 de novembro de 2026

Conclusão Primária (Estimado)

18 de janeiro de 2027

Conclusão do estudo (Estimado)

18 de janeiro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

8 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

8 de novembro de 2026

Primeira postagem (Real)

16 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

8 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever